LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.58
EUR
-0.02
EUR
-0.79 %
09:38:01
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.85 USD | 0.01 USD | 0.46 % |
|---|
| Vortag | 2.84 USD | Datum | 17.06.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Injective Staking ETP | CH1360612134 | 69.67% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 66.65% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 63.28% | |
| 21Shares Stellar ETP | CH1109575535 | 47.61% | |
| 21Shares Ondo ETP | CH1396389921 | 40.44% | |
| 21shares Gram Staking ETP | CH1297762812 | 29.09% | |
| 21Shares Jupiter ETP | CH1480821383 | 15.18% | |
| 21Shares Pendle ETP | CH1495416997 | 13.34% | |
| 21Shares XDC Network ETP | CH1464217285 | -5.30% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -8.57% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 179.15% | |
| 21shares Canton Network ETP | CH1503127917 | 106.21% | |
| 21shares Morpho ETP | CH1506167027 | 65.30% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 53.61% | |
| 21Shares Render ETP | CH1396343266 | 29.54% | |
| 21Shares Injective Staking ETP | CH1360612134 | 6.92% | |
| 21Shares Jupiter ETP | CH1480821383 | 1.37% | |
| 21Shares Bittensor ETP | CH1495416971 | 0.90% | |
| 21Shares Pendle ETP | CH1495416997 | -26.45% | |
| 21Shares Dogecoin ETP | CH1431521033 | -36.07% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 6.97% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 0.83% | |
| 21Shares Stellar ETP | CH1109575535 | -3.07% | |
| 21Shares Binance BNB ETP | CH0496454155 | -10.58% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -30.06% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -35.95% | |
| 21Shares Dogecoin ETP | CH1431521033 | -51.20% | |
| 21Shares Injective Staking ETP | CH1360612134 | -52.33% | |
| 21Shares Immutable ETP | CH1360612142 | -65.63% | |
| 21Shares Sui Staking ETP | CH1360612159 | -73.72% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Stellar ETP | CH1109575535 | 164.44% | |
| 21Shares XRP ETP | CH0454664043 | 128.26% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 53.38% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 19.07% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -1.57% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 727’071.13 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 19.06.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 52.10 | |
| Performance 2 Jahre | 49.29 | |
| Performance 3 Jahre | 5.30 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |